CClinicalTrials.gg
Active, not recruitingNCT05656924Updated Apr 28, 2026

Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees

A Phase 2 interventional study of digital prosthetic interface technology in Diabetes Type 2 and Amputation, sponsored by Spaulding Rehabilitation Hospital. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by Spaulding Rehabilitation Hospital · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The study will test a new approach to the design and implementation of socket and liner technology in individuals who lost a lower limb secondary to diabetes mellitus type II (herein referred to as dysvascular amputees). The technology-based intervention will be combined with an exercise program designed to improve the health status of dysvascular amputees.

Read the detailed description

The study will test the hypothesis that the use of a digital approach to the design and implementation of socket and liner technology (herein referred to as "digital prosthetic interface technology") leads to better health of the residuum (compared to traditional socket and liner technology). This hypothesis will be tested by recruiting a group of dysvascular amputees (herein meant to refer to individuals who lost a lower limb secondary diabetes mellitus type II) and by randomizing them to either receiving a digital prosthetic interface technology or a traditional socket and liner system. Furthermore, the study will assess if the digital prosthetic interface technology improves adherence to an exercise program and results in better clinical outcomes. To test this hypothesis, an exercise intervention will be deployed by relying on coaching and mobile health technology to encourage adherence to a walking program targeting dysvascular transtibial amputees. This exercise intervention is an extension of pilot work that demonstrated the suitability of mobile health technology to implement an exercise-based intervention program in dysvascular amputees.

02

Conditions studied

  • Diabetes Type 2
  • Amputation
03

In context

Diabetes Mellitus, Type 2

9,359 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,318 are open to participants now.

This study's planned enrollment of 38 is below the median of 80 across 7,525 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

Spaulding Rehabilitation Hospital is the lead sponsor of 114 studies on the registry; 26 are open to participants now.

Of its 19 completed or terminated interventional studies of FDA-regulated products, 17 (89%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Unilateral transtibial amputation within the past 6 years
  • Etiology secondary to complications of Diabetes Mellitus (DM) type II
  • Current use of a prosthesis, with at least 2 months prior use
  • K2 or K3 level (as determined using the Amputee Mobility Predictor assessment tool)
  • Own a smartphone

Exclusion criteria

Exclusion Criteria:

  • Amputation due to cancer or macrotrauma or acute hemorrhage
  • Bilateral amputation
  • Medically or surgically unstable contralateral lower extremity as determined by medical criteria (e.g., critical limb ischemia)
  • Severe residual limb pain that limits function preventing participation in an exercise-based program
  • Medical conditions that would interfere with subject's participation in regular sustained exercise
  • Anthropometric characteristics that are not compatible with the technology used to scan the residuum and manufacture the liner and socket (e.g., a residuum circumference greater than 32 inches would not be compatible with the device used to scan the residuum)
  • Current pregnancy
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
38 participants (estimated)

Study arms

  • Experimental
    digital prosthetic interface technology group

    Study participants randomized to this group will use the digital prosthetic interface technology developed by Bionic Skins.

    Device: digital prosthetic interface technology

  • No intervention
    traditional socket and liner technology group

    Study participants randomized to this group will use a traditional socket-liner technology (i.e., study participants will use their own liner and socket system).

Interventions

  • Devicedigital prosthetic interface technology

    Individuals randomized to this group will receive a socket and liner that are manufactured using a novel technique meant to achieve a better distribution of pressure on the residuum. The study is based on the hypothesis that an improvement in pressure distribution on the residuum will enable high adherence to an exercise program meant to improve health status in dysvascular amputees.

06

What researchers measure

Primary outcomes

  1. Difference in intra-socket interface pressure between the two groups

    Pressure sensors inserted in the socket will be used to measure the pressure on the residuum when study participants are weight bearing. The pressure is measured in kilopascals (kPa). 1 kPa is approximately the pressure exerted by a 10-g mass resting on a 1-cm2 area.

    Time frame: Baseline

  2. Difference in step counts between the two groups

    The average number of steps over a period of 2 weeks will be provided by a wearable sensor (Oura ring). The data will be expressed in number of steps per day.

    Time frame: 12 months

Secondary outcomes

  1. Difference in thermal imaging measures of the temperature of the residuum in the two groups

    A thermal camera will be used to measure the peak temperature of the residuum. The residuum temperature will be measured in degrees Celsius.

    Time frame: Baseline

  2. Difference in Socket Evaluation Questionnaire (SEQ) scores in the two groups

    The Socket Evaluation Questionnaire (SEQ) consists of a battery of questions inquiring about subject's comfort using a socket. The SEQ uses a visual analog scale format. The output ranges from 0 (worst) to 100 (best).

    Time frame: Baseline

  3. Difference in Prosthesis Evaluation Questionnaire (PEQ) scores in the two groups

    The Prosthesis Evaluation Questionnaire (PEQ) consists of a battery of questions inquiring about subject's perception of his/her prosthesis. The PEQ uses a visual analog scale format. The output ranges from 0 (worst) to 100 (best).

    Time frame: Baseline

07

Study locations

1 site
  • Spaulding Rehabilitation Hospital Boston
    Boston, Massachusetts 02129, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05656924
Lead sponsor
Spaulding Rehabilitation Hospital
Collaborators
Bionic Skins LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Responsible party
Paolo Bonato (Director, Motion Analysis Laboratory, Spaulding Rehabilitation Hospital) — Principal investigator
First posted
Dec 19, 2022
Start date
Dec 20, 2023
Primary completion
Feb 28, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Apr 28, 2026

Study contacts

Paolo Bonato, PhD
principal investigator · Spaulding Rehabilitation Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion